SEC Filings
Williams Closes $5.1 Billion Momentum Deal While Carrying A $1.6 Billion Working Capital Deficit
The Momentum price allocation is still preliminary, and $2.2 billion of long-term debt comes due within a year.
SEC Filings
The Momentum price allocation is still preliminary, and $2.2 billion of long-term debt comes due within a year.
SEC Filings
A $128.9 million one-off national-security project helped U.S. revenue climb 30.6%, covering a Kuwait-driven slide abroad.
SEC Filings
Royalty financing and new convertible notes outweigh a $551.1 million cash and investments pile on Syndax's balance sheet.
SEC Filings
The patent licensor named Dipti Vachani CEO, and its CFO says a few deals may slip past year-end but the high end of the range is still in reach.
SEC Filings
Two subsidiaries will retire the notes at face value plus accrued interest, ahead of their July 2027 due date.
SEC Filings
The amended deal adds a year and drops the termination option, while Tempus separately pays $12.0 million to license Recursion's RNA model.
SEC Filings
The airline sold $600 million of notes due 2029 and $650 million due 2031 through eleven banks.
SEC Filings
Ansuman Satpathy and Joseph Gilliam joined the board as Class III directors, and Gilliam now chairs the audit committee.
SEC Filings
Buybacks fell to $19.9 million last quarter as the all-stock deal turned into a $123.00-per-share cash purchase.
SEC Filings
The Class II director told AbbVie's board on Wednesday she would resign effective Monday, saying no dispute with the company was involved.
SEC Filings
The subsidiary's revolver amendment also trims interest margins by 25 basis points and pushes maturity out to as late as October 2030.
SEC Filings
Stokely gives up the interim Executive Chair title but stays board chair, and the extra fees for him and David Whalen end.